Analyses of tumor-specific T cell dynamics and tumor immune contexture in microsatellite instability-high cancers in response to first-line therapy

被引：0

作者：

Eissmann, Moritz ^{[1
]}

Huber, Anne ^{[1
]}

Allam, Amr ^{[1
]}

Dijkstra, Christine ^{[1
]}

Ernst, Matthias ^{[1
]}

机构：

[1] Olivia Newton John Canc Res Inst, Heidelberg, Vic, Australia

来源：

CANCER RESEARCH | 2022年 / 82卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

253

引用

页数：2

共 50 条

[1] The tumor immune microenvironment shapes response to pembrolizumab in microsatellite instability-high endometrial cancer
How, Jeffrey
Dang, Minghao
Euscher, Elizabeth
Yates, Melinda
Peng, Weiyi
Patel, Shrina
Lu, Karen
Hwu, Patrick
Naing, Aung
Wang, Linghua
Jazaeri, Amir
GYNECOLOGIC ONCOLOGY, 2021, 162 : S308 - S308
[2] Immune microenvironmental heterogeneity according to tumor DNA methylation phenotypes in microsatellite instability-high colorectal cancers
Kim, Jung Ho
Hong, Jiyun
Lee, Ji Ae
Jung, Minsun
Choi, Eunwoo
Cho, Nam-Yun
Kang, Gyeong Hoon
Kim, Sangwoo
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (11)
[3] The impact of the tumor immune microenvironment on response to pembrolizumab in patients with microsatellite instability-high endometrial cancer.
How, Jeffrey A.
Dao, Minghao
Euscher, Elizabeth
Yates, Melinda
Peng, Weiyi
Patel, Shrina D.
Lu, Karen H.
Hwu, Patrick
Wang, Linghua
Jazaeri, Amir A.
CLINICAL CANCER RESEARCH, 2021, 27 (03)
[4] Prognostic impact of early tumor shrinkage and depth of response in patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors
Fuca, Giovanni
Corti, Francesca
Ambrosini, Margherita
Intini, Rossana
Salati, Massimiliano
Fenocchio, Elisabetta
Manca, Paolo
Manai, Chiara
Daniel, Francesca
Raimondi, Alessandra
Morano, Federica
Corallo, Salvatore
Prisciandaro, Michele
Spallanzani, Andrea
Quara, Virginia
Belli, Carmen
Vaiani, Marta
Curigliano, Giuseppe
Cremolini, Chiara
De Braud, Filippo
Di Bartolomeo, Maria
Zagonel, Vittorina
Lonardi, Sara
Pietrantonio, Filippo
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (04)
[5] Inflamed human oropharyngeal cancers with ongoing tumor-specific T cell responses comprise a different type of immune suppressive T cells
Santegoets, S. J.
Duurland, C. L.
Jordanova, E. S.
van Ham, V. J.
Ehsan, I.
Welters, M. J.
van der Burg, S. H.
ANNALS OF ONCOLOGY, 2018, 29
[6] Tumor Response Dynamics During First-Line Pembrolizumab Therapy in Patients With Advanced Non-Small-Cell Lung Cancer
Nishino, Mizuki
Hong, Fangxin
Ricciuti, Biagio
Hatabu, Hiroto
Awad, Mark M.
JCO PRECISION ONCOLOGY, 2021, 5 : 501 - 509
[7] The immune response to class I-associated tumor-specific cutaneous T-cell lymphoma antigens
Berger, CL
Wang, N
Christensen, I
Longley, J
Heald, P
Edelson, RL
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 107 (03) : 392 - 397
[8] Personalization of T-Cell Therapy Using a High-Throughput Platform to Identify Tumor-Specific T-Cell Receptors
Zong, Shan
Cooper, Laurence J. N.
McNamara, George T.
Torikai, Hiroki
BLOOD, 2016, 128 (22)
[9] Tumor response criteria for assessing pazopanib first-line therapy in patients with metastatic renal cell carcinoma (mRCC)
Shiva Gupta
Hyunseon C. Kang
Jia Sun
Marc R. Matrana
Nizar M. Tannir
Haesun Choi
Abdominal Radiology, 2020, 45 : 1872 - 1882
[10] Tumor response criteria for assessing pazopanib first-line therapy in patients with metastatic renal cell carcinoma (mRCC)
Gupta, Shiva
Kang, Hyunseon C.
Sun, Jia
Matrana, Marc R.
Tannir, Nizar M.
Choi, Haesun
ABDOMINAL RADIOLOGY, 2020, 45 (06) : 1872 - 1882

← 1 2 3 4 5 →